Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -158.1% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 0.4 | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | -18.7% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-20 | 8.28 | (4.70) | (2.69)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-21 | 5.68 | (8.08) | (4.45)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-22 | 11.11 | (8.32) | (2.77)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-23 | 2.98 | (14.12) | (5.49)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-24 | 2.42 | (4.30) | (0.33)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Interim Results | 30-Jun-2025 | 15:03 | RNS |
Building for Humanity – Contract Update | 19-Jun-2025 | 14:34 | RNS |
Holding(s) in Company | 04-Jun-2025 | 11:49 | RNS |
Versarien extends deal with Montana Quimica | 04-Jul-2025 | ShareCast |
Versarien court date scheduled after case manage... | 02-May-2025 | ShareCast |
Versarien subsidiary awarded EUR 0.8m grant | 13-Dec-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 0.015p |
Change Today | 0.002p |
% Change | 15.38 % |
52 Week High | 0.11 |
52 Week Low | 0.013 |
Volume | 327,652,345 |
Shares Issued | 6,010m |
Market Cap | £0.90m |
Beta | 0.00 |
RiskGrade | 561 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 1,000,000 @ 0.015p |
16:35 | 589,783 @ 0.015p |
16:35 | 576 @ 0.015p |
16:35 | 235,589 @ 0.015p |
16:35 | 174,052 @ 0.015p |
Finance Director | Christopher Leigh |
CEO | Stephen Hodge |
You are here: research